Wren Therapeutics is a biopharmaceutical company based, focused on drug discovery and development for protein misfolding diseases.
Wren Therapeutics has raised €34M across 2 funding rounds from 1 investor, most recently a round in Feb 2021. Based in Cambridge, UK; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2021-02-03 | Other | €14M | — | View deal → |
| 2019-01-01 | Series A | €20M | The Baupost Group | View deal → |
